K-numberK242558
Device nameHalyard Black Nitrile Powder-Free Exam Gloves with Textured Grip Technology, Tested for Use with Chemotherapy Drugs, Fentanyl Citrate, Simulated Gastric Acid and Fentanyl in Simulated Gastric Acid
ApplicantO&M Halyard, Inc.
Product codeLZA
Device classClass I
Decision dateDec 17, 2024
DecisionSubstantially Equivalent
Regulation880.6250
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

Halyard Black Nitrile Powder-Free Exam Gloves with Textured Grip Technology are disposable, non-sterile medical examination gloves worn on the examiner's hand to prevent contamination between patient and examiner. These gloves have been tested for resistance to permeation by chemotherapy drugs, fentanyl citrate, and simulated gastric acid solutions, with specific labeling warnings for drugs showing breakthrough within defined timeframes.

Technological characteristics

The subject device is a 9.5-inch, black-colored, chlorinated, nitrile, powder-free, textured glove with ambidextrous design and non-sterile status, available in sizes XS through XXL. It features textured surfaces on dorsal and palmar sides through the fingertips. Compared to the predicate K220373, both share identical dimensional, material, and design characteristics; the subject device maintains the same textured grip technology and sizing.

Test standards cited

ASTM D6319-19 (Nitrile Examination Gloves specification), ASTM D6124-06 (Residual Powder), ASTM D5151-06 (Holes detection), ASTM D6978-05 (Chemotherapy drug permeation resistance), ISO 10993-11:2017 (Systemic toxicity), ISO 10993-10:2021 (Skin sensitization), and ISO 10993-23:2021 (Irritation).

Substantial equivalence argument

The subject device is substantially equivalent because it is physically and functionally identical to the predicate K220373 in material composition, design, dimensions, and manufacturing (both are 9.5-inch chlorinated nitrile powder-free textured gloves). All biocompatibility and performance testing demonstrates equivalent or superior safety and effectiveness, with the subject device passing the same ASTM chemotherapy permeation testing protocol and showing no breakthrough for the same panel of drugs up to 240 minutes. The only difference—textured grip technology nomenclature—represents no meaningful change in device performance or safety.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →